Nephrology clinical trials recruiting in Texas

48 recruiting nephrology trials match in Texas. Showing 20.

• A Study of Praliciguat in Participants With Focal Segmental Glomerulosclerosis (FSGS)Recruiting

  Phase 2 · Akebia Therapeutics · Arlington, Texas

• SPYRAL GEMINI Pilot StudyRecruiting

  N/A · Medtronic Vascular · Dallas, Texas

• Prehabilitation for Kidney Transplant CandidatesRecruiting

  N/A · The Methodist Hospital Research Institute · Houston, Texas

• Study of Orellanine in Metastatic Clear-Cell or Papillary Renal Cell CarcinomaRecruiting

  Phase 1 / Phase 2 · Oncorena AB · Houston, Texas

• Shingrix in Renal Transplant RecipientsRecruiting

  Phase 3 · University of Colorado, Denver · Houston, Texas

• Phosphate Assessment in Chronic Kidney Disease Patients StudyRecruiting

  N/A · University of Texas Southwestern Medical Center · Dallas, Texas

• Sickle Cell Kidney BiorepositoryRecruiting

  N/A · University of Texas Southwestern Medical Center · Dallas, Texas

• Risk of Acute Complications With Rocuronium vs Cisatracurium in Patients With Chronic Kidney DiseaseRecruiting

  Phase 4 · The University of Texas Medical Branch, Galveston · Galveston, Texas

• PReSeRVE-HD: Observational Study of the Merit HeRO® Graft and Super HeRO® in Patients on HemodialysisRecruiting

  N/A · Merit Medical Systems, Inc. · Dallas, Texas

• A Study to Learn More About How Safe the Study Treatment Finerenone is in Long-term Use When Taken With an ACE Inhibitor or Angiotensin Receptor Blocker Over 18 Months of Use in Children and Young Adults From 1 to 18 Years of Age With Chronic Kidney Disease and ProteinuriaRecruiting

  Phase 3 · Bayer · Buenos Aires

• Open-label Extension Study of Zigakibart in Adults With IgA Nephropathy.Recruiting

  Phase 3 · Novartis Pharmaceuticals · Dallas, Texas

• A Phase 2 Study of MZE829 in Adults With APOL1 Kidney DiseaseRecruiting

  Phase 2 · Maze Therapeutics · Dallas, Texas

• A Study to Evaluate the Safety and Effectiveness of the InnAVasc Arteriovenous Graft for Hemodialysis Access in Patients With End-Stage Renal DiseaseRecruiting

  N/A · W.L.Gore & Associates · Houston, Texas

• Study to Assess the Effects of ALN-ANG3 in Adult Participants With Diabetic Kidney DiseaseRecruiting

  Phase 2 · Regeneron Pharmaceuticals · Arlington, Texas

• A Study to Investigate Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of AZD4248 in Healthy Participants and Participants With Chronic Kidney Disease and Type 2 Diabetes and to Assess Home Measurements of Creatinine in a Non Interventional CohortRecruiting

  Phase 1 · AstraZeneca · San Antonio, Texas

• Behavioral AI to Predict and Increase Peritoneal Dialysis UptakeRecruiting

  N/A · Scaled Insights · Dallas, Texas

• Sotagliflozin to Slow Kidney Function Decline in Persons With Type 1 Diabetes and Diabetic Kidney DiseaseRecruiting

  Phase 3 · Alessandro Doria · Dallas, Texas

• Effect of the Amplifi™ Vein Dilation System on Outflow Vein Dilation and AV Fistula Maturation (AMPLIFI-1)Recruiting

  N/A · Amplifi Vascular, Inc. · Houston, Texas

• A Trial of Etelcalcetide in Pediatric Participants With Secondary Hyperparathyroidism and Chronic Kidney Disease on HemodialysisRecruiting

  Phase 3 · Amgen · Los Angeles, California

• A Study to Evaluate Safety, Tolerability and Efficacy of AP306 at Fixed Doses in Dialysis Participants With HyperphosphatemiaRecruiting

  Phase 2 · R1 Therapeutics · Greenville, Texas

Source: ClinicalTrials.gov. Recruitment status changes often — confirm on each study page.